Remyelination in humans due to a retinoid‐X receptor agonist is age‐dependent

Abstract Remyelination efficiency declines with advancing age in animal models, but this has been harder to demonstrate in people with multiple sclerosis. We show that bexarotene, a putatively remyelinating retinoid‐X receptor agonist, shortened the visual evoked potential latency in patients with c...

Full description

Bibliographic Details
Main Authors: Christopher E. McMurran, Trisha Mukherjee, J William L. Brown, Andrew W. Michell, Declan T. Chard, Robin J. M. Franklin, Alasdair J. Coles, Nick G. Cunniffe
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.51595